DOX Quote, Financials, Valuation and Earnings

Data Storage has a net margin of 13.62% compared to Amdocs's net margin of 2.11%. Amdocs's return on equity of 13.99% beat Data Storage's return on equity of 0.8%.

Amdocs has a consensus price target of $101.61, signalling upside risk potential of 13.74%. On the other hand Data Storage has an analysts' consensus of $9.00 which suggests that it could grow by 155.32%. Given that Data Storage has higher upside potential than Amdocs, analysts believe Data Storage is more attractive than Amdocs.

Amdocs has a beta of 0.506, which suggesting that the stock is 49.442% less volatile than S&P 500. In comparison Data Storage has a beta of 1.180, suggesting its more volatile than the S&P 500 by 17.975%.

Amdocs has a quarterly dividend of $0.53 per share corresponding to a yield of 2.2%. Data Storage offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Amdocs pays 42.98% of its earnings as a dividend. Data Storage pays out -- of its earnings as a dividend. Amdocs's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Amdocs quarterly revenues are $1.1B, which are larger than Data Storage quarterly revenues of $5.8M. Amdocs's net income of $151.1M is higher than Data Storage's net income of $122.4K. Notably, Amdocs's price-to-earnings ratio is 20.73x while Data Storage's PE ratio is 50.36x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amdocs is 2.07x versus 1.01x for Data Storage. Usually stocks with elevated PS ratios are considered overvalued.

Intellinetics has a net margin of 13.62% compared to Amdocs's net margin of -1.26%. Amdocs's return on equity of 13.99% beat Intellinetics's return on equity of -5.34%.

Amdocs has a consensus price target of $101.61, signalling upside risk potential of 13.74%. On the other hand Intellinetics has an analysts' consensus of $17.50 which suggests that it could grow by 20.94%. Given that Intellinetics has higher upside potential than Amdocs, analysts believe Intellinetics is more attractive than Amdocs.

Amdocs has a beta of 0.506, which suggesting that the stock is 49.442% less volatile than S&P 500. In comparison Intellinetics has a beta of 0.548, suggesting its less volatile than the S&P 500 by 45.204%.

Amdocs has a quarterly dividend of $0.53 per share corresponding to a yield of 2.2%. Intellinetics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Amdocs pays 42.98% of its earnings as a dividend. Intellinetics pays out -- of its earnings as a dividend. Amdocs's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Amdocs quarterly revenues are $1.1B, which are larger than Intellinetics quarterly revenues of $4.3M. Amdocs's net income of $151.1M is higher than Intellinetics's net income of -$53.7K. Notably, Amdocs's price-to-earnings ratio is 20.73x while Intellinetics's PE ratio is 248.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amdocs is 2.07x versus 3.47x for Intellinetics. Usually stocks with elevated PS ratios are considered overvalued.

Signing Day Sports has a net margin of 13.62% compared to Amdocs's net margin of -2893.73%. Amdocs's return on equity of 13.99% beat Signing Day Sports's return on equity of --.

Amdocs has a consensus price target of $101.61, signalling upside risk potential of 13.74%. On the other hand Signing Day Sports has an analysts' consensus of -- which suggests that it could fall by --. Given that Amdocs has higher upside potential than Signing Day Sports, analysts believe Amdocs is more attractive than Signing Day Sports.

Amdocs has a beta of 0.506, which suggesting that the stock is 49.442% less volatile than S&P 500. In comparison Signing Day Sports has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Amdocs has a quarterly dividend of $0.53 per share corresponding to a yield of 2.2%. Signing Day Sports offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Amdocs pays 42.98% of its earnings as a dividend. Signing Day Sports pays out -- of its earnings as a dividend. Amdocs's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Amdocs quarterly revenues are $1.1B, which are larger than Signing Day Sports quarterly revenues of $55.4K. Amdocs's net income of $151.1M is higher than Signing Day Sports's net income of -$1.6M. Notably, Amdocs's price-to-earnings ratio is 20.73x while Signing Day Sports's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amdocs is 2.07x versus 0.44x for Signing Day Sports. Usually stocks with elevated PS ratios are considered overvalued.

WidePoint has a net margin of 13.62% compared to Amdocs's net margin of -1.23%. Amdocs's return on equity of 13.99% beat WidePoint's return on equity of -20.12%.

Amdocs has a consensus price target of $101.61, signalling upside risk potential of 13.74%. On the other hand WidePoint has an analysts' consensus of $6.50 which suggests that it could grow by 29.74%. Given that WidePoint has higher upside potential than Amdocs, analysts believe WidePoint is more attractive than Amdocs.

Amdocs has a beta of 0.506, which suggesting that the stock is 49.442% less volatile than S&P 500. In comparison WidePoint has a beta of 1.805, suggesting its more volatile than the S&P 500 by 80.475%.

Amdocs has a quarterly dividend of $0.53 per share corresponding to a yield of 2.2%. WidePoint offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Amdocs pays 42.98% of its earnings as a dividend. WidePoint pays out -- of its earnings as a dividend. Amdocs's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Amdocs quarterly revenues are $1.1B, which are larger than WidePoint quarterly revenues of $34.6M. Amdocs's net income of $151.1M is higher than WidePoint's net income of -$425.2K. Notably, Amdocs's price-to-earnings ratio is 20.73x while WidePoint's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amdocs is 2.07x versus 0.33x for WidePoint. Usually stocks with elevated PS ratios are considered overvalued.